MiMedx joins Russell 3000 and 2000 Indexes
- BySeeking Alpha-
MiMedx Group (MDXG) will join the Russell 3000 and Russell 2000 Indexes following the 2021 Russell indexes reconstitution, effective June 28after the U.S. market opens
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
MiMedx Group Inc (MDXG)
NASDAQ
Symbol | Exchange | Currency |
|---|
11.82
+0.22(+1.90%)
- Volume:302,052
- Bid/Ask:9.51/12.00
- Day's Range:11.60 - 12.02
MDXG Overview
- Prev. Close
- 11.6
- Day's Range
- 11.6-12.02
- Revenue
- 246.47M
- Open
- 11.75
- 52 wk Range
- 5.32-13.01
- EPS
- -0.81
- Volume
- 302,052
- Market Cap
- 1.32B
- Dividend (Yield)
- N/A(N/A)
- Average Vol. (3m)
- 2,548,084
- P/E Ratio
- -
- Beta
- 1.64
- 1-Year Change
- 114.91%
- Shares Outstanding
- 111,718,544
- Next Earnings Date
- Aug 03, 2021
What is your sentiment on MiMedx Group Inc?
or
Market is currently closed. Voting is open during market hours.
MiMedx Group Inc News
- New Therapeutic Drugs for Tendinitis Treatment Coming Down the Pipeline
- ByBenzinga-
Los Angeles, USA, June 21, 2021 (GLOBE NEWSWIRE) -- New Therapeutic Drugs for Tendinitis Treatment Coming Down the Pipeline There are around 4+ key companies that are...
- New Study Demonstrates Potential for MIMEDX Purion® Processed Dehydrated Human Amnion/Chorion Membrane to Modulate Pathological Scar Tissue Formation
- ByBenzinga-
Proposed Mechanism Suggests Potential Path to Improve Outcomes in Clinical Applications where the Regulation of Excessive Fibrosis Can Promote a Normal Healing ResponseComplex...
MiMedx Group Inc Analysis
- MiMedx: Aggressively Adding Shares Here
- BySeeking Alpha-
- Are Options Traders Betting On A Big Move In MiMedx Group (MDXG) Stock?
Investors in MiMedx Group, Inc. (NASDAQ:MDXG) need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 20th 2018 $17.50 Put...
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Neutral | Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Sell | Sell | Strong Buy | Strong Buy | Strong Buy |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,660.30 | 2,668.00 | 2,596.00 | +91.9 | +3.58% | 2.08M | NASDAQ | |||
| 369.79 | 375.33 | 357.19 | +18.60 | +5.30% | 33.69M | NASDAQ | |||
| 26.16 | 26.18 | 26.11 | +0.03 | +0.11% | 58.09K | ||||
| 28.10 | 29.75 | 27.05 | -0.77 | -2.67% | 7.64M | ||||
| 5.28 | 5.34 | 5.28 | +0.020 | +0.38% | 1.33M | ||||
| 6.12 | 6.18 | 6.05 | +0.010 | +0.16% | 18.03M | ||||
| 29.52 | 29.90 | 29.03 | -0.10 | -0.34% | 1.11M | ||||
| 138.35 | 139.32 | 137.52 | +0.38 | +0.28% | 1.53M | ||||
| 20.97 | 20.99 | 20.19 | +0.54 | +2.64% | 1.16M | ||||
| 57.94 | 57.99 | 56.10 | +1.00 | +1.76% | 548.07K | ||||
| 195.58 | 197.00 | 192.50 | -0.36 | -0.18% | 19.57M | NASDAQ | |||
| 27.19 | 27.47 | 26.92 | +0.14 | +0.52% | 4.93M | ||||
| 20.57 | 20.57 | 20.57 | +0.17 | +0.83% | 100.00 | ||||
| 192.18 | 193.25 | 189.69 | +2.22 | +1.17% | 528.47K | ||||
| 192.66 | 193.43 | 190.64 | +1.62 | +0.85% | 1.34M |
MiMedx Group Inc Company Profile
MiMedx Group Inc Company Profile
MiMedx Group, Inc. is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company's Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories. Its biomaterial platform technologies include AmnioFix, EpiFix, OrthoFlo, Physio, AlloBurn, and CollaFix. AmnioFix and EpiFix are its tissue technologies processed from human amniotic membrane derived from donated placentas. OrthoFlo is amniotic fluid-derived allograft for homologous use. Physio is a bone grafting material consists of bone tissue with no added carrier. CollaFix, its new brand, is its collagen fiber technology designed to mimic the natural composition, structure and mechanical properties of musculoskeletal tissues in order to augment their repair.
Read More
- 2019-02-19 13:26:56
https://www.presciencepoint.com/research/research-archives/mimedx/. . . READ - 2019-02-13 15:13:54
gap up to zero. no financials, no cash, no future but lawsuits- 2019-11-21 12:13:16spoken like someone who has no clue
- 2018-09-28 15:50:44$mdxg going to gap up. $15 must
- 2018-11-13 01:32:14
Lol you couldn’t possibly be more wrong
- 2018-09-27 18:54:15The trend is super bullish.
- 2018-09-27 18:53:48I am refinancing my house and will buy more soon. Not selling until $15.
- 2019-01-03 20:13:56Im sorry for your loss
- 2018-09-24 15:50:27$10 coming soon
- 2018-07-02 15:18:36CEO and COO resign and investigation of accounting continues
- 2018-07-02 14:26:25today it dropped to $4.20
- 2017-10-24 15:15:55Short now
- 2016-07-09 12:19:20
mDXG is a big buy with 42% upside to a current price at $8.07- 2017-05-03 01:01:28Seems you were correct
- 2018-03-09 17:05:35
For a while...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.